You are here

  • Home
  • Archive
  • Volume 106, Issue 7
  • Efficacy of a novel personalised aflibercept monotherapy regimen based on polypoidal lesion closure in participants with polypoidal choroidal vasculopathy

Article metrics

Article menu
Download PDFPDF
Clinical science
Efficacy of a novel personalised aflibercept monotherapy regimen based on polypoidal lesion closure in participants with polypoidal choroidal vasculopathy

 

Online download statistics by month:

Online download statistics by month: February 2021 to August 2024

AbstractFullPdf
Feb 202124933839
Mar 202124402821
Apr 20213812023
May 202112396
Jun 2021151511
Jul 2021251616
Aug 20211598
Sep 202116126
Oct 2021259816
Nov 2021284109
Dec 202125057
Jan 202220297
Feb 202227648
Mar 202231588
Apr 202234997
May 2022349910
Jun 20228293716
Jul 20227833019
Aug 20223212624
Sep 20222762110
Oct 2022279197
Nov 20222161321
Dec 20228851
Jan 20236823
Feb 20239741
Mar 202310774
Apr 20237795
May 20238643
Jun 202313188
Jul 20236787
Aug 20235342
Sep 20235286
Oct 20236033
Nov 20236851
Dec 20236753
Jan 202410094
Feb 2024136169
Mar 202475165
Apr 20243311
May 20248613
Jun 20247453
Jul 20246643
Aug 20245952
Total12146484376